AAPL325.90-0.70 (-0.21%) ▼|ABBV255.44+2.06 (+0.81%) ▲|ABT101.56-0.10 (-0.10%) ▼|ACN142.90-1.83 (-1.26%) ▼|ADBE229.06-5.68 (-2.42%) ▼|AMAT560.93+35.23 (+6.70%) ▲|AMD525.38+21.81 (+4.33%) ▲|AMGN367.54+3.37 (+0.93%) ▲|AMT164.90-2.16 (-1.29%) ▼|AMZN247.17-2.82 (-1.13%) ▼|AVGO382.16+4.00 (+1.06%) ▲|AXP351.94+0.01 (+0.00%) ▲|BA210.80+1.32 (+0.63%) ▲|BAC60.79+0.37 (+0.61%) ▲|BKNG178.79-0.66 (-0.37%) ▼|BLK1,059.56+5.45 (+0.52%) ▲|BMY60.53+0.37 (+0.62%) ▲|BNY158.42+1.49 (+0.95%) ▲|BRK-B490.08-1.17 (-0.24%) ▼|C131.93+3.21 (+2.49%) ▲|CAT881.98+17.68 (+2.05%) ▲|CL91.04-0.90 (-0.97%) ▼|CMCSA23.82+0.04 (+0.15%) ▲|COF205.51-1.26 (-0.61%) ▼|COP116.63+0.95 (+0.82%) ▲|COST930.60-5.20 (-0.56%) ▼|CRM170.78-3.01 (-1.73%) ▼|CSCO111.78+1.08 (+0.98%) ▲|CVS109.00+1.39 (+1.29%) ▲|CVX190.10+0.39 (+0.21%) ▲|DE585.12-0.89 (-0.15%) ▼|DHR175.59-25.53 (-12.69%) ▼|DIS96.29-0.12 (-0.12%) ▼|DUK125.15-0.70 (-0.56%) ▼|EMR137.79+1.21 (+0.89%) ▲|FDX314.98+8.76 (+2.86%) ▲|GD372.84+2.24 (+0.60%) ▲|GE344.68+3.38 (+0.99%) ▲|GEV1,085.71+6.53 (+0.61%) ▲|GILD132.48-0.73 (-0.55%) ▼|GM78.65+2.85 (+3.76%) ▲|GOOG348.71-2.66 (-0.76%) ▼|GOOGL349.30-2.69 (-0.76%) ▼|GS1,079.21+24.18 (+2.29%) ▲|HD329.22-3.82 (-1.15%) ▼|HON229.48+3.30 (+1.46%) ▲|IBM210.63-2.37 (-1.11%) ▼|INTC102.63+5.57 (+5.74%) ▲|INTU289.31-4.51 (-1.54%) ▼|ISRG361.07+7.90 (+2.24%) ▲|JNJ250.09+1.27 (+0.51%) ▲|JPM342.90+4.03 (+1.19%) ▲|KO81.86-0.27 (-0.32%) ▼|LIN508.76-3.29 (-0.64%) ▼|LLY1,162.73+15.83 (+1.38%) ▲|LMT504.54-5.00 (-0.98%) ▼|LOW202.62-2.09 (-1.02%) ▼|LRCX317.36+10.60 (+3.45%) ▲|MA542.28-5.16 (-0.94%) ▼|MCD264.86-2.78 (-1.04%) ▼|MDLZ59.50-0.77 (-1.28%) ▼|MDT82.86-0.43 (-0.52%) ▼|META647.09+1.24 (+0.19%) ▲|MMM174.64+15.53 (+9.76%) ▲|MO73.85-0.81 (-1.08%) ▼|MRK126.02+1.62 (+1.30%) ▲|MS215.71+4.77 (+2.26%) ▲|MSFT400.11-2.18 (-0.54%) ▼|MU924.05+58.59 (+6.77%) ▲|NEE87.87-0.13 (-0.14%) ▼|NFLX67.68+0.08 (+0.12%) ▲|NKE43.10-0.38 (-0.86%) ▼|NOW103.09-1.61 (-1.54%) ▼|NVDA205.21+1.93 (+0.95%) ▲|ORCL125.23+3.85 (+3.17%) ▲|PEP134.73-0.73 (-0.54%) ▼|PFE24.95+0.20 (+0.81%) ▲|PG147.75-1.38 (-0.93%) ▼|PLTR133.72-1.13 (-0.84%) ▼|PM191.29-1.43 (-0.74%) ▼|QCOM171.95+1.63 (+0.96%) ▲|RTX196.69+2.25 (+1.16%) ▲|SBUX104.78-0.04 (-0.03%) ▼|SCHW102.79+0.25 (+0.24%) ▲|SO93.71-0.76 (-0.80%) ▼|SPG229.40+1.21 (+0.53%) ▲|T22.01+0.06 (+0.25%) ▲|TMO519.19-7.04 (-1.34%) ▼|TMUS192.53-3.11 (-1.59%) ▼|TSLA381.19+11.62 (+3.14%) ▲|TXN291.73+7.66 (+2.69%) ▲|UBER71.95-0.23 (-0.31%) ▼|UNH432.29+10.74 (+2.55%) ▲|UNP294.88-1.37 (-0.46%) ▼|UPS115.44+2.29 (+2.02%) ▲|USB63.16+0.02 (+0.02%) ▲|V357.72-2.85 (-0.79%) ▼|VZ43.35-0.15 (-0.34%) ▼|WFC86.94+0.61 (+0.71%) ▲|WMT111.17-1.03 (-0.92%) ▼|XOM150.40+2.04 (+1.37%) ▲|AAPL325.90-0.70 (-0.21%) ▼|ABBV255.44+2.06 (+0.81%) ▲|ABT101.56-0.10 (-0.10%) ▼|ACN142.90-1.83 (-1.26%) ▼|ADBE229.06-5.68 (-2.42%) ▼|AMAT560.93+35.23 (+6.70%) ▲|AMD525.38+21.81 (+4.33%) ▲|AMGN367.54+3.37 (+0.93%) ▲|AMT164.90-2.16 (-1.29%) ▼|AMZN247.17-2.82 (-1.13%) ▼|AVGO382.16+4.00 (+1.06%) ▲|AXP351.94+0.01 (+0.00%) ▲|BA210.80+1.32 (+0.63%) ▲|BAC60.79+0.37 (+0.61%) ▲|BKNG178.79-0.66 (-0.37%) ▼|BLK1,059.56+5.45 (+0.52%) ▲|BMY60.53+0.37 (+0.62%) ▲|BNY158.42+1.49 (+0.95%) ▲|BRK-B490.08-1.17 (-0.24%) ▼|C131.93+3.21 (+2.49%) ▲|CAT881.98+17.68 (+2.05%) ▲|CL91.04-0.90 (-0.97%) ▼|CMCSA23.82+0.04 (+0.15%) ▲|COF205.51-1.26 (-0.61%) ▼|COP116.63+0.95 (+0.82%) ▲|COST930.60-5.20 (-0.56%) ▼|CRM170.78-3.01 (-1.73%) ▼|CSCO111.78+1.08 (+0.98%) ▲|CVS109.00+1.39 (+1.29%) ▲|CVX190.10+0.39 (+0.21%) ▲|DE585.12-0.89 (-0.15%) ▼|DHR175.59-25.53 (-12.69%) ▼|DIS96.29-0.12 (-0.12%) ▼|DUK125.15-0.70 (-0.56%) ▼|EMR137.79+1.21 (+0.89%) ▲|FDX314.98+8.76 (+2.86%) ▲|GD372.84+2.24 (+0.60%) ▲|GE344.68+3.38 (+0.99%) ▲|GEV1,085.71+6.53 (+0.61%) ▲|GILD132.48-0.73 (-0.55%) ▼|GM78.65+2.85 (+3.76%) ▲|GOOG348.71-2.66 (-0.76%) ▼|GOOGL349.30-2.69 (-0.76%) ▼|GS1,079.21+24.18 (+2.29%) ▲|HD329.22-3.82 (-1.15%) ▼|HON229.48+3.30 (+1.46%) ▲|IBM210.63-2.37 (-1.11%) ▼|INTC102.63+5.57 (+5.74%) ▲|INTU289.31-4.51 (-1.54%) ▼|ISRG361.07+7.90 (+2.24%) ▲|JNJ250.09+1.27 (+0.51%) ▲|JPM342.90+4.03 (+1.19%) ▲|KO81.86-0.27 (-0.32%) ▼|LIN508.76-3.29 (-0.64%) ▼|LLY1,162.73+15.83 (+1.38%) ▲|LMT504.54-5.00 (-0.98%) ▼|LOW202.62-2.09 (-1.02%) ▼|LRCX317.36+10.60 (+3.45%) ▲|MA542.28-5.16 (-0.94%) ▼|MCD264.86-2.78 (-1.04%) ▼|MDLZ59.50-0.77 (-1.28%) ▼|MDT82.86-0.43 (-0.52%) ▼|META647.09+1.24 (+0.19%) ▲|MMM174.64+15.53 (+9.76%) ▲|MO73.85-0.81 (-1.08%) ▼|MRK126.02+1.62 (+1.30%) ▲|MS215.71+4.77 (+2.26%) ▲|MSFT400.11-2.18 (-0.54%) ▼|MU924.05+58.59 (+6.77%) ▲|NEE87.87-0.13 (-0.14%) ▼|NFLX67.68+0.08 (+0.12%) ▲|NKE43.10-0.38 (-0.86%) ▼|NOW103.09-1.61 (-1.54%) ▼|NVDA205.21+1.93 (+0.95%) ▲|ORCL125.23+3.85 (+3.17%) ▲|PEP134.73-0.73 (-0.54%) ▼|PFE24.95+0.20 (+0.81%) ▲|PG147.75-1.38 (-0.93%) ▼|PLTR133.72-1.13 (-0.84%) ▼|PM191.29-1.43 (-0.74%) ▼|QCOM171.95+1.63 (+0.96%) ▲|RTX196.69+2.25 (+1.16%) ▲|SBUX104.78-0.04 (-0.03%) ▼|SCHW102.79+0.25 (+0.24%) ▲|SO93.71-0.76 (-0.80%) ▼|SPG229.40+1.21 (+0.53%) ▲|T22.01+0.06 (+0.25%) ▲|TMO519.19-7.04 (-1.34%) ▼|TMUS192.53-3.11 (-1.59%) ▼|TSLA381.19+11.62 (+3.14%) ▲|TXN291.73+7.66 (+2.69%) ▲|UBER71.95-0.23 (-0.31%) ▼|UNH432.29+10.74 (+2.55%) ▲|UNP294.88-1.37 (-0.46%) ▼|UPS115.44+2.29 (+2.02%) ▲|USB63.16+0.02 (+0.02%) ▲|V357.72-2.85 (-0.79%) ▼|VZ43.35-0.15 (-0.34%) ▼|WFC86.94+0.61 (+0.71%) ▲|WMT111.17-1.03 (-0.92%) ▼|XOM150.40+2.04 (+1.37%) ▲|
23.6 C
New York
Tuesday, July 21, 2026

Tag: health technology

newssourceFORcompanyinformationcontent1releasesmarket

Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®

COPENHAGEN, Denmark, June 26, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company has been added to the broad-market Russell 3000® Index, the large-cap Russell 1000® Index, the small-to-mid-cap Russell 2500® Index, and the Russell Midcap® Index as a part of the 2026 Russell U.S. Indexes semi-annual reconstitution, effective at the close of U.S. equity markets on June 26, 2026.

FDA Clears PanopticAI’s Contactless Respiratory Rate Measurement

Following the startup's first FDA 510 (k) clearance for its contactless pulse rate monitoring, PanopticAI has now secured a second one for respiratory rate...

Mother Nature AI Reveals Three-Specialist AI Platform as It Approaches 5 Million Users and Launches $8.5 Million Capital Raise

New York health technology company combines general wellness, mental health, and nutrition AI into a single personalized ecosystem - and prepares its Vital IQ™ wearable for market 
New York health technology company combines general wellness, mental health, and nutrition AI into a single personalized ecosystem - and prepares its Vital IQ™ wearable for market

Philips helps customers rethink flexibility with the IntelliVue Patient Monitor 6000 Series

June 17, 2026

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) demonstrated sustained efficacy and safety in adults with hypoparathyroidism. Over the three-and-a-half-year duration of the trial, TransCon PTH replicated the systemic actions of endogenous PTH, with a balanced, beneficial impact on the main target organ systems – CNS, kidney, small intestine, and bone – as demonstrated by improved quality of life and normalized and stable urine calcium, serum calcium, serum phosphate, and bone mineral density. These benefits were sustained while enabling independence from conventional therapy with active vitamin D and calcium.

Exilby® Receives First European Marketing Authorization as VERTANICAL Prepares UK Submission for its First-in-Class Non-Opioid Treatment for Chronic Low Back Pain

GRÄFELFING, Germany, June 9, 2026 /PRNewswire/ -- VERTANICAL today announced that Exilby® (VER-01) has received marketing authorization in Germany for the treatment of chronic...

Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results

MILPITAS, Calif., June 8, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the...

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.

SKG Launches PS700 Neck Massager, Bringing Deep Kneading, Layered Heat, and Immersive Audio to Everyday Recovery

The new wearable recovery device pairs deep-kneading massage, layered warmth, and immersive audio to help ease neck tension 
The new wearable recovery device pairs deep-kneading massage, layered warmth, and immersive audio to help ease neck tension

WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland

June 4, 2026

Philips announces exchange ratio for 2025 dividend

June 2, 2026

West Appoints Michel Lagarde to be President and Chief Executive Officer

Experienced healthcare and life sciences executive to lead the Company's next phase of growth and innovationEXTON, Pa., June 1, 2026 /PRNewswire/ -- West Pharmaceutical...

Instinct Science Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies

PHILADELPHIA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Instinct Science, a leading innovator in veterinary workflow, decision support, education, and practice management software, has been named to the Inc. 5000 list of the fastest-growing private companies in America, earning the #388 spot overall, ranking #6 in Pennsylvania, and #37 in Software companies nationwide.

Herz P1 Smart Ring: 24/7 Health Monitoring, Sleep, Stress & Heart Rate Tracking

WuzuTech's Herz P1 Smart Ring: Revolutionizing Wellness with 24/7 Health Monitoring, Real-Time Insights, and Continuous Tracking 
WuzuTech's Herz P1 Smart Ring: Revolutionizing Wellness with 24/7 Health Monitoring, Real-Time Insights, and Continuous Tracking

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsHealth technology

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers